FDA Okays Tradjenta As Add-On Therapy To Insulin

apg_1288890396

Eli Lilly and Co. (LLY:Quote) said Friday that the U.S. Food and Drug Administration has approved a supplemental new drug application, or sNDA, for Tradjenta tablets for use as add-on therapy to insulin.

Read more

Posted in Drugs